Sort by
Refine Your Search
-
transformations, advanced materials processing and characterisation. Supervisor: Dr David Collins Stipend: Full funding for 4 years covering a personal maintenance stipend starting at £20,780 (current rate). Fees
-
advanced materials processing. Closing date for applications: 2 Dec 2025 with interviews shortly afterwards. Stipend: Full funding for 4 years covering a personal maintenance stipend starting at £20,780
-
production processes and are actively exploring the incorporation of new materials, technologies and designs in their operations to achieve zero-carbon construction elements. The construction industry is under
-
advanced materials processing. Closing date for applications: 2 Dec 2025 with interviews shortly afterwards. Stipend: Full funding for 4 years covering a personal maintenance stipend starting at £20,780
-
transformations, and advanced materials processing. Closing date for applications: 2 Dec 2025 with interviews shortly afterwards. Stipend: Full funding for 4 years covering a personal maintenance stipend starting
-
also throughout the development phase, which involves transforming a molecule into a medicine and addressing various chemistry, manufacturing, and control (CMC) challenges. A key aspect of this process
-
their properties, as well as develop ways to manipulate and advance the nano-assembly processes. You would also be involved in scale-up on roll-to-roll pre-pilot kit, to explore applications for these advanced
-
both sites. The project sits at the interface of cell line engineering, protein science and machine learning and you will receive advanced training in these areas while developing methods to accelerate
-
and Technology (CST) at the University of Cambridge. The goal of this PhD programme is to launch one "deceptive by design" project that combines the perspectives of human-computer interaction (HCI) and
-
cancer, novel genetically engineered mouse models for the depletion of different CAF populations, in vitro three-dimensional pancreatic tumour organoid/fibroblast co-culture models, CRISPR-based